There is no science stating that COVID-19 patients should receive medicines costing between 800 and 3000 USD per dose.
COVID-19 guidelines for therapeutics apply to hospitalized patients, and recommendations differ. There are not any drugs designed to treat COVID-19 specifically, but anti-virals and steroids are sometimes used. A publication by the Journal of Viral Eradication has estimated the cost of production for drugs that can be repurposed to treat COVID-19. These therapeutic medicines' minimum average estimated production costs are less than $1 per day. According to the report, current prices of these drugs were higher than production costs, particularly in the U.S. The cost of interventional therapeutics used to treat COVID-19 varies based on the quantity produced and raw materials for drug production. Cost-effectiveness modeling is just one of several approaches to consider reasonable pricing of medicine. Particularly in a public health emergency perspective on a large scale associated with COVID-19, the public and policymakers should consider various approaches. Therapeutics are prescribed based on the severity of the infection following strict medical standards. The severity of an individual's viral infection determines the overall cost of treatment. No one is recommending that COVID-19 patients should receive medicines costing between 800 and 3000 USD per dose. The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19, including symptoms, prevention, and available treatment, please refer to the World Health Organization or your national healthcare authority.